Kubota Pharma, Last Fiscal Year's Undisclosed Net Income to Narrow

Tue Feb 10, 2026 3:30 pm JST

Kubota Pharmaceutical Holdings Co., Ltd. <4596> [TSE Growth] announced a previously undisclosed earnings forecast after the market closed on February 10th (15:30). The consolidated net loss for the fiscal year ending December 2025 is expected to further decrease to loss of 0.65 billion yen (compared to a loss of 1.33 billion yen in the previous period).

Kabutan News

Guidance Update

Second Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul - Dec, 2025 Prev	ー	ー	ー	ー	－	0	Feb 14, 2025	IFRS
Jul - Dec, 2025 New	8	-427	-209	-209	-3.7	0	Feb 10, 2026	IFRS
Revision Rate	－	－	－	－	－

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2025 Prev	ー	ー	ー	ー	－	0	Feb 14, 2025	IFRS
Dec, 2025 New	21	-877	-659	-659	-11.7	0	Feb 10, 2026	IFRS
Revision Rate	－	－	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul - Dec, 2024	17	-670	-664	-664	-11.8	0	Feb 14, 2025	IFRS
Jul - Dec, 2025 Guidance	8	-427	-209	-209	-3.7	0	Feb 10, 2026	IFRS
YoY	-52.9%	+36.3%	+68.5%	+68.5%	+68.5%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2023	40	-1,504	-1,490	-1,490	-26.8	0	Feb 14, 2024	IFRS
Dec, 2024	27	-1,345	-1,333	-1,333	-23.7	0	Feb 14, 2025	IFRS
Dec, 2025 Guidance	21	-877	-659	-659	-11.7	0	Feb 10, 2026	IFRS
YoY	-22.2%	+34.8%	+50.6%	+50.6%	+50.6%